EUVIMEDEUVIMED entdecken
Open Access

Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers

Shuai Li iD, Laura Madanat-Harjuoja iD, Goska Leslie iD, Daniel R Barnes iD, Manjeet K Bolla iD, Joe Dennis iD, Michael T Parsons iD, Paraskevi Apostolou, Norbert Arnold iD, Kristin Bosse, EMBRACE Collaborators, Jackie Cook und 37 weitere

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djae306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Shuai Li und 48 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Austra…. Hauptthemen laut MEDLINE: Neoplasms, BRCA2 Protein, BRCA1 Protein, Genes, BRCA2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Career Continuity, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whether carriers of BRCA1 or BRCA2 pathogenic variants have increased risks of childhood, adolescent, and young adult cancers is controversial. We aimed to evaluate this risk and to inform clinical care of young BRCA1 and BRCA2 pathogenic variant carriers and genetic testing for childhood, adolescent, and young adult cancer patients.

Methods

Using data from 47 117 individuals from 3086 BRCA1 or BRCA2 families, we conducted pedigree analysis to estimate relative risks (RRs) for cancers diagnosed before age 30 years.

Results

Our data included 274 cancers diagnosed before age 30 years: 139 breast cancers, 10 ovarian cancers, and 125 nonbreast nonovarian cancers. Associations for breast cancer in young adulthood (aged 20-29 years) were found with relative risks of 11.4 (95% confidence interval [CI] = 5.5 to 23.7) and 5.2 (95% CI = 1.6 to 17.7) for BRCA1 and BRCA2 pathogenic variant carriers, respectively. No association was found for any other investigated childhood, adolescent, and young adult cancer or for all nonbreast nonovarian cancers combined; the relative risks were 0.4 (95% CI = 0.1 to 1.4) and 1.4 (95% CI = 0.7 to 3.0) in BRCA1 and BRCA2 pathogenic variant carriers, respectively.

Conclusion

We found no evidence that BRCA1 and BRCA2 pathogenic variant carriers have an increased childhood, adolescent, and young adult cancer risk aside from breast cancer in women aged between 20 and 30 years. Our results, along with a critical evaluation of previous germline sequencing studies, suggest that the childhood and adolescent cancer risk conferred by BRCA1 and BRCA2 pathogenic variant would be low (ie, RR < 2) if it existed. Our findings do not support pathogenic variant testing for offspring of BRCA1 and BRCA2 pathogenic variant carriers at ages younger than 18 years or for conducting BRCA1 and BRCA2 pathogenic variant testing for childhood and adolescent cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsBRCA2 ProteinBRCA1 ProteinGenes, BRCA2HumansFemaleAdultAdolescentYoung AdultGenetic Predisposition to DiseaseChildHeterozygoteMaleOvarian NeoplasmsGenetic TestingBreast NeoplasmsPedigreeRisk Factors

Substanzen

BRCA2 protein, humanBRCA1 protein, humanBRCA2 ProteinBRCA1 Protein

Autor:innen und Institutionen

  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia.
  • Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, United Kingdom.
  • Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki 00029, Finland.
  • Finnish Cancer Registry, Helsinki 00130, Finland.
  • Public Health Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

ORCID-Profile: Shuai Li, Laura Madanat-Harjuoja, Goska Leslie, Daniel R Barnes, Manjeet K Bolla, Joe Dennis, Michael T Parsons, Norbert Arnold, Christoph Engel, D Gareth Evans, Florentia Fostira, Megan N Frone, Mark H Greene, Karl Hackmann, Eric Hahnen, Nadia Harbeck, Jan Hauke, Louise Izatt, Marion Kiechle, Irene Konstantopoulou, Fiona Lalloo, Joanne Ngeow, Dieter Niederacher, Marc Tischkowitz, Vishakha Tripathi, Ana Vega, Hannah Wallaschek, Shan Wang-Gohrke, Barbara Wappenschmidt, Bernhard H F Weber, Drakoulis Yannoukakos, Douglas F Easton, Antonis C Antoniou, Georgia Chenevix-Trench, Lisa R Diller

Förderung

  • Career Continuity
  • Faculty of Medicine, Dentistry and Health Sciences
  • University of Melbourne
  • Cancer Research UK
  • Gray Foundation
  • NIHR
  • Cambridge Biomedical Research Centre
  • Department of Health and Social Care

Zitieren

APA

Li, S., Madanat-Harjuoja, L., Leslie, G., Barnes, D. R., Bolla, M. K., Dennis, J., Parsons, M. T., Apostolou, P., Arnold, N., Bosse, K., EMBRACE Collaborators, Cook, J., Engel, C., Evans, D. G., Fostira, F., Frone, M. N., Gehrig, A., Greene, M. H., Hackmann, K., …, & Diller, L. R. (2025). Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae306

Vancouver

Li S, Madanat-Harjuoja L, Leslie G, Barnes DR, Bolla MK, Dennis J, et al. Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae306

BibTeX
@article{Li2025,
  author = {Li, Shuai and Madanat-Harjuoja, Laura and Leslie, Goska and Barnes, Daniel R and Bolla, Manjeet K and Dennis, Joe and Parsons, Michael T and Apostolou, Paraskevi and Arnold, Norbert and Bosse, Kristin and EMBRACE Collaborators, EMBRACE Collaborators and Cook, Jackie and Engel, Christoph and Evans, D Gareth and Fostira, Florentia and Frone, Megan N and Gehrig, Andrea and Greene, Mark H and Hackmann, Karl and Hahnen, Eric and Harbeck, Nadia and Hauke, Jan and Hentschel, Julia and Horvath, Judit and Izatt, Louise and Kiechle, Marion and Konstantopoulou, Irene and Lalloo, Fiona and Ngeow, Joanne and Niederacher, Dieter and Ritter, Julia and Santamariña, Marta and Schmutzler, Rita K and Searle, Claire and Sutter, Christian and Tischkowitz, Marc and Tripathi, Vishakha and Vega, Ana and Wallaschek, Hannah and Wang-Gohrke, Shan and Wappenschmidt, Barbara and Weber, Bernhard H F and Yannoukakos, Drakoulis and Zhao, Emily and Easton, Douglas F and Antoniou, Antonis C and Chenevix-Trench, Georgia and Rebbeck, Timothy R and Diller, Lisa R},
  title = {Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djae306}
}
Kostenlos starten →